generalized epilepsy with febrile seizures plus, type 2
generalized epilepsy with febrile seizures plus, type 2
Explore linked clinical trials. Standard reference: MONDO:00114613 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome | Epilepsies, Myoclonic, Epilepsy, Generalized, Epileptic Syndromes, brain disorder, central nervous system disorder, epilepsy, generalized epilepsy with febrile seizures plus, type 2, nervous system disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-22 | NCT05419492 | |
| A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome | Epilepsies, Myoclonic, Epilepsy, Generalized, Epileptic Syndromes, brain disorder, central nervous system disorder, epilepsy, generalized epilepsy with febrile seizures plus, type 2, nervous system disorder | Recruiting | Early phase 1 | 2026-06-30 | NCT07675746 | |
| A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome (Australia Only) | Epilepsies, Myoclonic, Epilepsy, Generalized, Epileptic Syndromes, brain disorder, central nervous system disorder, epilepsy, generalized epilepsy with febrile seizures plus, type 2, nervous system disorder | Active, not recruiting | Phase 1 / Phase 2 | 2025-11-14 | NCT06112275 |